OGT Antibody

Catalog Number: ASB-OACA03397
Article Name: OGT Antibody
Biozol Catalog Number: ASB-OACA03397
Supplier Catalog Number: OACA03397
Alternative Catalog Number: ASB-OACA03397-100UG,ASB-OACA03397-50UG
Manufacturer: Aviva
Host: Rabbit
Category: Proteine/Peptide
Application: ELISA, IF, IHC
Species Reactivity: Human
Immunogen: Recombinant Human UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit protein (606-1022AA)
Conjugation: Unconjugated
Alternative Names: HINCUT-1,HRNT1,MRX106,O-GLCNAC,O-GlcNAc transferase p110 subunit,O-GlcNAc transferase subunit p110,OGT1,O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase),O-linked N-acetylglucosamine transferase 110 kDa subunit,UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,uridinediphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyl transferase,XLID106.
Catalyzes the transfer of a single N-acetylglucosamine from UDP-GlcNAc to a serine or threonine residue in cytoplasmic and nuclear proteins resulting in their modification with a beta-linked N-acetylglucosamine (O-GlcNAc) (PubMed:26678539). Glycosylates a large and diverse number of proteins including histone H2B, AKT1, EZH2, PFKL, KMT2E/MLL5, MAPT/TAU and HCFC1 (PubMed:26678539). Can regulate their cellular processes via cross-talk between glycosylation and phosphorylation or by affecting proteolytic processing (PubMed:26678539). Probably by glycosylating KMT2E/MLL5, stabilizes KMT2E/MLL5 by preventing its ubiquitination (PubMed:26678539). Involved in insulin resistance in muscle and adipocyte cells via glycosylating insulin signaling components and inhibiting the Thr-308 phosphorylation of AKT1, enhancing IRS1 phosphorylation and attenuating insulin signaling. Involved in glycolysis regulation by mediating glycosylation of 6-phosphofructokinase PFKL, inhibiting its activity (PubMed:22923583). Component of a THAP1/THAP3-HCFC1-OGT complex that is required for the regulation of the transcriptional activity of RRM1. Plays a key role in chromatin structure by mediating O-GlcNAcylation of Ser-112 of histone H2B: recruited to CpG-rich transcription start sites of active genes via its interaction with TET proteins (TET1, TET2 or TET3) (PubMed:22121020, PubMed:23353889). As part of the NSL complex indirectly involved in acetylation of nucleosomal histone H4 on several lysine residues (PubMed:20018852). O-GlcNAcylation of Ser-75 of EZH2 increases its stability, and facilitating the formation of H3K27me3 by the PRC2/EED-EZH2 complex (PubMed:24474760). Regulates circadian oscillation of the clock genes and glucose homeostasis in the liver. Stabilizes clock proteins ARNTL/BMAL1 and CLOCK through O-glycosylation, which prevents their ubiquitination and subsequent degradation. Promotes the CLOCK-ARNTL/BMAL1-mediated transcription of genes in the negative loop of the circadian clock such as PER1/2 and CRY1/2 (PubMed:12150998, PubMed:18288188, PubMed:19377461, PubMed:19451179, PubMed:20018868, PubMed:20200153, PubMed:21285374, PubMed:15361863). O-glycosylates HCFC1 and regulates its proteolytic processing and transcriptional activity (PubMed:21285374, PubMed:28584052, PubMed:28302723).
Clonality: Polyclonal
NCBI: 8473
Form: Liquid
Immunohistochemistry of paraffin-embedded human breast cancer at dilution 1:100
Immunohistochemistry of paraffin-embedded human lung cancer at dilution of 1:100
Immunohistochemistry of paraffin-embedded human placenta tissue at dilution 1:100